Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Mol Biol Rep ; 51(1): 674, 2024 May 24.
Artigo em Inglês | MEDLINE | ID: mdl-38787497

RESUMO

BACKGROUND: Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system (CNS) with inflammation and immune dysfunction. OBJECTIVES: We compared the remyelination and immunomodulation properties of mesenchymal stem cells (MSCs) with their conditioned medium (CM) in the cuprizone model. METHODS: Twenty-four C57BL/ 6 mice were divided into four groups. After cuprizone demyelination, MSCs and their CM were injected into the right lateral ventricle of mice. The expression level of IL-1ß, TNF-α, and BDNF genes was evaluated using the qRT-PCR. APC antibody was used to assess the oligodendrocyte population using the immunofluorescent method. The remyelination and axonal repair were studied by specific staining of the LFB and electron microscopy techniques. RESULTS: Transplantation of MSCs and CM increased the expression of the BDNF gene and decreased the expression of IL-1ß and TNF-α genes compared to the cuprizone group, and these effects in the cell group were more than CM. Furthermore, cell transplantation resulted in a significant improvement in myelination and axonal repair, which was measured by luxol fast blue and transmission electron microscope images. The cell group had a higher number of oligodendrocytes than other groups. CONCLUSIONS: According to the findings, injecting MSCs intraventricularly versus cell-conditioned medium can be a more effective approach to improving chronic demyelination in degenerative diseases like MS.


Assuntos
Cuprizona , Doenças Desmielinizantes , Modelos Animais de Doenças , Inflamação , Transplante de Células-Tronco Mesenquimais , Células-Tronco Mesenquimais , Camundongos Endogâmicos C57BL , Animais , Transplante de Células-Tronco Mesenquimais/métodos , Camundongos , Células-Tronco Mesenquimais/metabolismo , Doenças Desmielinizantes/induzido quimicamente , Doenças Desmielinizantes/patologia , Meios de Cultivo Condicionados/farmacologia , Inflamação/patologia , Inflamação/metabolismo , Fator Neurotrófico Derivado do Encéfalo/metabolismo , Fator Neurotrófico Derivado do Encéfalo/genética , Interleucina-1beta/metabolismo , Interleucina-1beta/genética , Oligodendroglia/metabolismo , Remielinização , Esclerose Múltipla/patologia , Esclerose Múltipla/terapia , Esclerose Múltipla/metabolismo , Esclerose Múltipla/induzido quimicamente , Fator de Necrose Tumoral alfa/metabolismo , Masculino , Bainha de Mielina/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA